The Investor
26 Mar 2026, 23:09
Prosus leads $18 million funding round in Brazilian healthtech Mevo
March 26, 2026 — Prosus has led an $18 million funding round in Mevo, a leading Brazilian e-prescription platform, to accelerate the digital transformation of healthcare services.
The investment will support Mevo’s expansion of its integrated platform, which connects patients, healthcare providers, pharmacies, and pharmaceutical companies across the care journey. The company expects to serve around 20 million patients through digital prescriptions in 2026.
Mevo’s platform is already integrated with more than 1,100 healthcare institutions and seven major insurers, covering roughly 30% of Brazil’s private healthcare market. It also connects with over 1,600 pharmacy locations.
Prosus said the investment reflects its confidence in digital healthcare as a major growth opportunity, positioning Mevo at the center of a more connected and efficient healthcare ecosystem in Brazil.
March 26, 2026 — Prosus has led an $18 million funding round in Mevo, a leading Brazilian e-prescription platform, to accelerate the digital transformation of healthcare services.
The investment will support Mevo’s expansion of its integrated platform, which connects patients, healthcare providers, pharmacies, and pharmaceutical companies across the care journey. The company expects to serve around 20 million patients through digital prescriptions in 2026.
Mevo’s platform is already integrated with more than 1,100 healthcare institutions and seven major insurers, covering roughly 30% of Brazil’s private healthcare market. It also connects with over 1,600 pharmacy locations.
Prosus said the investment reflects its confidence in digital healthcare as a major growth opportunity, positioning Mevo at the center of a more connected and efficient healthcare ecosystem in Brazil.